Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01169207 · ClinicalTrials.gov registry record
Johns Hopkins Crohn's Disease and Ulcerative Colitis Study
A clinical trial of Inflammatory Bowel Disease, sponsored by Johns Hopkins University.
- Active
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT01169207: Active study of Inflammatory Bowel Disease, sponsored by Johns Hopkins University.
NCT01169207 is a study of Inflammatory Bowel Disease that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 2,500 participants, above the 315-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (694% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01169207, a study of Inflammatory Bowel Disease, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a idiopathic, chronic and frequently disabling inflammatory disorder of the intestines characterized by a dysregulated mucosal immune response that affect more than a million Americans. This current protocol was established in 1996 with the goal of identifying the genetic and environmental components that contribute to the development of IBD, especially in families.
Conditions Studied
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 1996-07 |
| Est. Completion | 2027-12 |
What the registry record for NCT01169207 still lists
NCT01169207 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 315-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (694% higher).
The record links to 1 condition, with Inflammatory Bowel Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01169207 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01169207 about?
NCT01169207 is a clinical study titled "Johns Hopkins Crohn's Disease and Ulcerative Colitis Study". Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a idiopathic, chronic and frequently disabling inflammatory disorder of the intestines characterized by a dysregulated mucosal immune response that affect more than a million Americans. This current prot...
What is the current status of trial NCT01169207?
This trial is currently active not recruiting. The enrollment target is 2,500 participants. The study started on 1996-07. Estimated completion is 2027-12.
What conditions does trial NCT01169207 study?
This clinical trial studies the following conditions: Inflammatory Bowel Disease.
Who is sponsoring clinical trial NCT01169207?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01169207 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Bowel Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01169207's enrollment target sits among peer trials
2,500 1st of 28 higher than 28 of 28 other Inflammatory Bowel Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammatory Bowel Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Morning Light Therapy in IBD
RECRUITING · NA
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RECRUITING
-
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
RECRUITING
-
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
RECRUITING
-
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia